Global Healthcare Opportunities, a European specialist investor in healthcare, has acquired Genesis Research, a provider of tech-enabled Real-World Evidence and health economics and outcomes research services.
Genesis provides tech-enabled data and science first services across the life sciences industries. The firm optimizes drug development and evidences the clinical and commercial value of products through expert analysis and utilization of real-world data.
“The investment in Genesis follows years of work internally to identify market leading platforms with ambitious management teams in RWE and HEOR,” said the partners at GHO Capital. “With our investment and specialist expertise, we look forward to supporting the shared ambition for Genesis to become a global leader in RWE and HEOR.”
“GHO is a strong partner with healthcare expertise to accelerate our growth and expand our global footprint, which will in turn strengthen the capabilities across the sector leading to better healthcare outcomes,” added Frank Corvino, CEO of Genesis.
Ropes & Gray acted as legal advisor to GHO; CIL as commercial advisor; Alvarez and Marsal as financial advisor; Deloitte LLP as tax advisor and CRS as insurance advisor